98 results
Page 3 of 5
8-K
EX-99.1
8ufbmrgg8g59u
1 May 20
Glycomimetics Reports Operational Highlights and Financial Results for
9:00am
8-K
EX-99.1
yueb1vmwzz es4etk
28 Feb 20
Glycomimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
11:00am
8-K
eyg6hjo pwq97l3ufad
7 Jan 20
GLYCOMIMETICS AND APOLLOMICS Announce Exclusive Collaboration and License Agreement to Develop and Commercialize UPROLESELAN and GMI-1687
4:00pm
8-K
EX-99.1
d020 hrlvkls
7 Nov 19
Glycomimetics Reports Third Quarter 2019 Financial
8:35am
8-K
EX-99.1
x2k4 xquq4zfmx
5 Aug 19
Glycomimetics Reports Top-line Results from Pfizer’s Phase 3 Clinical Trial Evaluating Rivipansel In Sickle Cell Disease
4:30pm
8-K
EX-99.1
2yc72nd
1 Aug 19
Glycomimetics Reports Second Quarter 2019 Financial
8:35am